-
LSD and Psilocybin Related Documents and Resources
-
New Database Prepared for LSD-Study in Accordance with FDA Best Practices
-
LSD-Assisted Therapy for Anxiety Associated with Life-Threatening Illness
-
Swiss LSD/End-of-Life Anxiety Study Moving Forward; Protocol Amendment Accepted by IRB
-
Amendment to LSD Protocol Submitted to Swiss Ethics Committee
-
Eighth Subject Enrolled in LSD Trial
-
Swiss LSD Study is Renewed for Another Year by SwissMedic
-
Sixth Subject Enrolled in LSD Study
-
“Inside LSD” Broadcast on National Geographi
-
LSDs long strange trip back into the lab
-
We submitted to the FDA the
-
Swiss LSD/End-of-Life Study Receives $25,695
-
LSD-Assisted Therapy for 12 People with Anxiety Related to Life-Threatening Illness
-
Swiss LSD/End-of-Life Anxiety Study Annual Report Completed
-
MAPS Transfers $25,000 To The Swiss LSD Study
-
FDA Removes Clinical Hold on LSD Research – A Transformative Moment in Psychedelic History
-
Benefits of Magic Mushroom Therapy Long Lasting
-
A Really Long Strange Trip
-
Psilocybin Study Hints at Rebirth of Hallucinogen Research
-
Study finds long benefit in illegal mushroom drug
